|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.46 USD | -2.45% |
|
+0.56% | -37.50% |
| Capitalization | 12.69B 10.79B 10.09B 9.48B 17.47B 1,151B 19.08B 118B 45.49B 542B 47.6B 46.6B 1,970B | P/E ratio 2026 * |
18.3x | P/E ratio 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise value | 15.72B 13.37B 12.51B 11.75B 21.64B 1,426B 23.64B 146B 56.36B 671B 58.98B 57.74B 2,441B | EV / Sales 2026 * |
2.42x | EV / Sales 2027 * | 2.31x |
| Free-Float |
94.01% | Yield 2026 * |
4.79% | Yield 2027 * | 4.97% |
Last Transcript: The Clorox Company
| 1 day | -2.41% | ||
| 1 week | +0.56% | ||
| Current month | -5.97% | ||
| 1 month | +0.29% | ||
| 3 months | -17.36% | ||
| 6 months | -18.10% | ||
| Current year | -37.50% |
| 1 week | 101.04 |  | 104.86 |
| 1 month | 98.2 | | 108.18 |
| Current year | 98.2 | | 164.22 |
| 1 year | 98.2 | | 166.35 |
| 3 years | 98.2 | | 178.2 |
| 5 years | 98.2 | | 231.11 |
| 10 years | 98.2 | | 239.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Rendle
CEO | Chief Executive Officer | 47 | 2020-09-13 |
Luc Bellet
DFI | Director of Finance/CFO | 47 | 2025-03-31 |
Chau Banks
CTO | Chief Tech/Sci/R&D Officer | 56 | 2020-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Esther Lee
BRD | Director/Board Member | 66 | 2013-08-18 |
| Director/Board Member | 67 | 2015-06-30 | |
Allan Mackay
BRD | Director/Board Member | 70 | 2016-08-14 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.44% | +0.56% | -38.26% | -30.66% | 12.69B | |
| -0.40% | +1.25% | +23.06% | +3.75% | 53.93B | |
| +0.41% | +4.09% | -19.73% | +4.11% | 20.32B | |
| -1.90% | -4.80% | +37.97% | -45.34% | 6B | |
| -0.37% | +2.27% | -13.13% | -20.97% | 5.14B | |
| +1.66% | +3.12% | -11.46% | +10.93% | 2.89B | |
| +1.52% | +10.97% | -22.00% | +29.79% | 2.76B | |
| +0.83% | -0.94% | +15.74% | +70.18% | 1.43B | |
| 0.00% | -2.34% | -31.61% | +33.71% | 1.15B | |
| -0.21% | -1.96% | +12.49% | +183.82% | 807M | |
| Average | -0.06% | +0.15% | -4.69% | +23.93% | 10.71B | |
| Weighted average by Cap. | -0.30% | +0.25% | +3.92% | -0.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.5B 5.52B 5.17B 4.85B 8.94B 589B 9.77B 60.26B 23.29B 277B 24.38B 23.86B 1,009B | 6.81B 5.79B 5.41B 5.09B 9.37B 617B 10.24B 63.12B 24.4B 291B 25.53B 25B 1,057B |
| Net income | 703M 598M 560M 526M 968M 63.8B 1.06B 6.52B 2.52B 30.03B 2.64B 2.58B 109B | 797M 678M 634M 596M 1.1B 72.29B 1.2B 7.39B 2.86B 34.03B 2.99B 2.93B 124B |
| Net Debt | 3.03B 2.58B 2.41B 2.27B 4.17B 275B 4.56B 28.12B 10.87B 129B 11.38B 11.14B 471B | 3.05B 2.59B 2.43B 2.28B 4.2B 276B 4.59B 28.27B 10.93B 130B 11.44B 11.2B 473B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-15 | 101.50 $ | -2.41% | 1,738,785 |
| 25-12-12 | 104.01 $ | +1.15% | 1,435,798 |
| 25-12-11 | 102.83 $ | +0.30% | 1,519,625 |
| 25-12-10 | 102.52 $ | +1.08% | 2,068,466 |
| 25-12-09 | 101.42 $ | +0.49% | 1,925,770 |
Delayed Quote Nyse, December 15, 2025 at 03:11 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CLX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition